Anti-Dog IL31 Antibody (SAA2425) from ProteoGenix; catalogue ARO-A22873; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-Dog IL31 Antibody (SAA2425) is a highly specific and potent antibody designed for the detection and neutralization of Interleukin 31 (IL31) in dogs. This antibody has been extensively tested and validated for use in various research applications and has shown excellent results in both in vitro and in vivo studies.
IL31 is a cytokine that plays a crucial role in the regulation of allergic and inflammatory responses in dogs. It is primarily produced by activated T cells and has been linked to various skin disorders in dogs, such as atopic dermatitis and pruritus. The Anti-Dog IL31 Antibody (SAA2425) specifically targets this cytokine and can effectively block its activity, making it an essential tool for studying the role of IL31 in these conditions.
One of the main applications of the Anti-Dog IL31 Antibody (SAA2425) is its use in ELISA assays for the quantitative measurement of IL31 levels in biological samples. This antibody has been shown to have high sensitivity and specificity, making it an ideal choice for accurate and reliable detection of IL31 in dog serum, plasma, and tissue lysates.
In addition to ELISA, the Anti-Dog IL31 Antibody (SAA2425) has also been successfully used in Western blotting, immunohistochemistry, and flow cytometry experiments. Its ability to specifically bind to IL31 makes it a valuable tool for studying the expression and localization of this cytokine in different tissues and cell types.
Furthermore, the Anti-Dog IL31 Antibody (SAA2425) has been used in various experimental models to investigate the role of IL31 in different disease states. For example, it has been used to study the effects of IL31 on skin inflammation and itch in dogs, providing valuable insights into the mechanisms underlying these conditions.
In summary, the Anti-Dog IL31 Antibody (SAA2425) is a highly specific and reliable tool for the detection and neutralization of IL31 in dogs. Its versatility and effectiveness in various research applications make it an essential asset for scientists studying the role of IL31 in canine health and disease. Order now and discover the potential of this powerful antibody in your research.
ProteoGenix catalogue number ARO-A22873. For research use only.
Target: Interleukin 31, IL-31, IL31; Clonality: Monoclonal Antibody; Reactivity: Dog; Applications: ELISA, Neutralization.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | Neutralization |
|---|---|---|---|---|---|---|---|---|---|
| Dog |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
